The MedXM Medicare Advantage lawsuit filed in 2018 grew out of former employees’ allegations about assessment records, including visits that physicians said had never happened. One employee worked in data processing and raised concerns with a supervisor. Their account puts the people handling the paperwork inside a story usually told through diagnoses and insurance payments.
Mobile Medical Examination Services, known as MedXM, was based in Santa Ana, California. The company used physicians, nurse practitioners and physician assistants to conduct in-home health assessments. The assessment vendor produced information that insurers could use in seeking higher Medicare payments.
MedXM settled an earlier qui tam case brought by a former compliance officer over alleged changes to reports sent to insurers. That case was separate from the former employees’ lawsuit.
The court dismissed the former employees’ lawsuit in March 2020. The court’s docket names MedXM and health insurers as defendants.
The employees’ allegations reached both the assessment records and the response inside the company. One described physicians saying that visits had not occurred. The data-processing employee said concerns had been raised in at least three meetings with a supervisor. That second part matters to an insider: what reached management can be as revealing as the original entry.
A home assessment could generate a diagnosis that increased an insurer’s monthly Medicare payment. Under Medicare Advantage’s payment model, private plans receive a monthly amount for each enrollee, adjusted for expected health care costs. Diagnoses help determine that adjustment. The insurer reports the codes to the Centers for Medicare and Medicaid Services.
The Private Equity Stakeholder Project’s 2024 report, How Private Equity Gets Its Cut From Medicare Advantage, describes how the in-home assessment business developed to help insurers identify conditions that could raise risk scores and reimbursement. It describes visits devoted to assessment and screening, with no treatment provided. It puts the incentive in one line: the risk adjustment score rests on what the plan is expected to spend, not on what it actually spends.
That gives the assessment record a financial life beyond the visit. A vendor can supply the diagnosis documentation while the insurer submits the payment data.
The earlier MedXM case alleged that health assessment reports changed after they reached the company’s coders. The whistleblower, a former compliance officer, brought that lawsuit in 2013. The Ninth Circuit’s 2018 opinion describes the alleged sequence from examiner to coder to insurer. The plans named alongside MedXM included WellPoint, Health Net and Molina Healthcare.
The whistleblower alleged that the insurers hired MedXM to increase or maintain payments for enrollees whose risk scores were about to expire. Without updated diagnosis codes each year, those scores would revert to the Medicare beneficiary average.
According to the whistleblower’s allegations recounted by the court, examiners prepared reports in Microsoft Word templates and signed them by typing their names. The files remained editable. Coders allegedly deleted information showing little risk and inserted information supporting diagnoses with higher risk scores. MedXM then allegedly saved the reports as PDFs and sent them to the insurers as support for the diagnosis data.
The allegation puts the decisive change between two versions of the same report. The examiner’s original account and the file the insurer received could tell different stories about the same person. A completed PDF would show the result. The earlier version would show what changed.
The complaint alleged that MedXM reported chronic obstructive pulmonary disease, hepatitis and inflammatory bowel disease without the testing needed to confirm them. It said examiners and coders recycled earlier diagnoses and medical histories into updated assessments. The whistleblower also alleged that nurse practitioners and physician assistants worked without proper physician supervision.
The visit totals raised another question. The whistleblower estimated that a home assessment took about 45 minutes plus travel, allowing at most 13 visits per day. Some examiners allegedly reported as many as 25.
The whistleblower said identical vital statistics appeared for hundreds of enrollees and that MedXM corrected suspicious entries only when insurers asked. Those supposed corrections allegedly used information collected by telephone or new data forged by coders. The alleged edits made patients look sicker on paper so insurers could collect more taxpayer money.
A plan’s correction request can show what the insurer noticed and how the vendor answered. The final report alone would leave that exchange out.
The earlier complaint alleged that the insurers submitted MedXM’s invalid diagnosis data to CMS while knowing about the problems or disregarding them. The court described allegations that typed signatures and duplicate patient data gave the insurers reasons to question the reports.
The plan’s data certification was another part of that account. The insurer certified the accuracy, completeness and truthfulness of the risk-adjustment data it submitted. The alleged record changes happened at the vendor, but the payment submission and certification happened at the plan.
The Ninth Circuit allowed several claims against the insurers in this earlier case to proceed to evidence gathering.
An assessment diagnosis can generate Medicare payments even when it appears nowhere else in the patient’s service records. In an October 2024 report, the HHS Office of Inspector General estimated $7.5 billion in Medicare Advantage payments for 2023 from diagnoses appearing only on health risk assessments or chart reviews linked to those assessments, with no appearance on other service records for 2022.
The Inspector General raised two concerns: inaccurate diagnoses generating improper payments, or enrollees missing needed care for serious conditions. That brings the patient’s experience back into a process otherwise measured in codes and revenue. What happened after the assessment belongs beside what the assessment reported.
Cigna’s home-visit case supplies a concrete comparison. In its 2023 settlement announcement, the Justice Department described a patient given a congestive heart failure diagnosis even though the home-visit form recorded normal cardiac findings. The government alleged that the visits primarily captured lucrative diagnosis codes and that vendor clinicians could not provide patient treatment.
The vendor side appeared again in the Matrix Medical Network settlement announced in June 2026. Matrix agreed to pay $36.5 million over allegations that it caused insurers to submit invalid diagnoses generated through home assessments. The government alleged that the conditions frequently went undiagnosed by other providers who saw the same patients around the assessment year.
An assessment insider may know where the examiner’s account changed, who approved the final version or what happened when a plan questioned it. A coder sees the supporting note and the selected diagnosis. A vendor reviewer sees the report sent back for correction. A plan employee sees which healthcare data ultimately reached the submission.
We work with insiders to connect those parts: the original assessment, changes to the report, the signature, the insurer’s questions and the data sent for payment. The MedXM allegations show why the diagnosis trail includes the company’s response as well as the initial code. Your knowledge of how the work actually moved can explain a discrepancy that a final report hides.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you saw a diagnosis change between the home visit and the insurer’s file, tell our whistleblower experts how it happened. We build the case with you and bring in Medicare Advantage fraud whistleblower lawyers who understand assessment vendors, coding and plan submissions. We stay beside you as that inside knowledge becomes the evidence for your case.